Cellular signals integrate cell cycle and metabolic control in cancer

Chareeporn Akekawatchai1, Sarawut Jitrapakdee2

  • 1Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand; Thammasat University Research Unit in Diagnostic Molecular Biology of Chronic Diseases related to Cancer (DMB-CDC), Pathumthani, Thailand.

Insights

Growth factors (GFs) can drive cell proliferation by activating receptor tyrosine kinases (RTKs). Cell cycle regulators fine-tune cellular metabolism to support tumor growth, with imbalances potentially leading to apoptosis.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Metabolic Regulation

Background:

  • Growth factors (GFs) promote cell growth, differentiation, and survival.
  • Aberrant GF/receptor tyrosine kinase (RTK) signaling can lead to oncogenic transformation.
  • GF/RTK signaling influences major pathways like Ras/Erk and PI3K/Akt, driving cell cycle progression.

Purpose of the Study:

  • To explore the intricate relationship between cell cycle regulation and metabolic reprogramming in cancer.
  • To elucidate the role of specific cell cycle regulators in modulating metabolic pathways.
  • To understand how metabolic imbalances during the cell cycle contribute to cancer progression and cell fate.

Main Methods:

  • Review of accumulating evidence linking GF/RTK signaling to cell cycle progression.
  • Analysis of the role of key cell cycle regulators (cyclins, CDKs, APC/C-Cdh1) in metabolic control.
  • Investigation of post-translational modifications and transcriptional regulation of metabolic enzymes by cell cycle regulators.

Main Results:

  • GF signaling enables quiescent cells to re-enter the cell cycle and proliferate.
  • Tumor cells exhibit significant metabolic changes during proliferation to meet biomass and energy demands.
  • Cell cycle regulators (cyclin D, B, Cdk2, 4, 6, APC/C-Cdh1) critically control metabolic pathways.
  • Metabolic enzyme activity is regulated via post-translational mechanisms or transcriptional control by cell cycle regulators.
  • Precise metabolic pathway activation supports biosynthetic precursor availability during proliferation.

Conclusions:

  • Cell cycle regulators orchestrate metabolic reprogramming essential for tumor cell proliferation.
  • Imbalances in cellular metabolism during specific cell cycle phases can trigger cell cycle arrest and apoptosis.
  • Targeting the interplay between cell cycle and metabolism presents a potential therapeutic strategy in oncology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
What is the Cell Cycle?00:56

What is the Cell Cycle?

The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: the interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the...
6.6K